The minimally invasive, non-surgical intervention – transcatheter aortic valve implantation (TAVI) – is now available on Medicare for more privately insured patients living with severe aortic stenosis. From March 1, 2022, the TAVI Medicare Benefits Schedule (MBS) listing will be expanded to include patients deemed at intermediate surgical risk on the grounds of acceptable safety, … Continue reading TAVI now available on Medicare for more patients living with severe aortic stenosis